The impact of interrupting enzyme replacement therapy in late-onset Pompe disease

BACKGROUND: Late-onset Pompe disease (LOPD) is a rare autosomal recessive disorder caused by mutations in the GAA gene, leading to progressive weakness of locomotor and respiratory muscles. Enzyme replacement therapy (ERT), administered every second week, has been proven to slow down disease progres...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Neurol
Main Authors: Wenninger, Stephan, Gutschmidt, Kristina, Wirner, Corinna, Einvag, Krisztina, Montagnese, Federica, Schoser, Benedikt
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2021
Teme:
Original Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7903209/
https://ncbi.nlm.nih.gov/pubmed/33625582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-021-10475-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki